Fluvoxamine for COVID-19 ICU patients?
Br J Clin Pharmacol
.
2022 May;88(5):2454-2455.
doi: 10.1111/bcp.15166.
Epub 2022 Feb 7.
Author
Vladimir Trkulja
1
Affiliation
1
Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia.
PMID:
35132670
PMCID:
PMC9111198
DOI:
10.1111/bcp.15166
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Drug Treatment*
Fluvoxamine* / therapeutic use
Humans
Intensive Care Units
Selective Serotonin Reuptake Inhibitors
Substances
Serotonin Uptake Inhibitors
Fluvoxamine